AUG 22, 2020 8:07 AM PDT

New Class of Antibiotics Could Treat UTIs

WRITTEN BY: Nouran Amin

At 11 million cases annually, urinary tract infections (UTIs) are the most common outpatient infections in the U.S.,

Scientists are developing a new class of antibiotics against urinary tract infections (UTIS).

UTIs affect half of all women at least once in their life and antibiotic treatments are becoming increasingly resistant.

"You can't stop bacteria from evolving and developing resistance to antibiotics," says Mary Rose Ronquillo, an undergraduate student who works in the lab of Scott C. Eagon, Ph.D. "The aim of our research is to develop a drug that acts in a different way from current drugs -- by depriving the bacteria of iron, a key nutrient essential to their survival."

Learn more about UTIs:

Scientists are now reporting an early progress toward creating a class of antibiotics that would target infections by starving the culprit bacterium from iron.  Their results were presented at the American Chemical Society (ACS) Fall 2020 Virtual Meeting & Expo.

"We selected one of these compounds as a scaffold to modify into potential small molecule inhibitors of the TonB system," M. Cole Detels, an undergraduate student in Eagon's lab, explains. The molecule is called 2-{[(3-chloro-4-methoxyphenyl)amino]methyl}quinolin-8-ol, or more simply, the "hydroxyquinoline scaffold."

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 11, 2020
Cancer
A New CDK Inhibitor Could Help with Unresponsive Liver Cancer
NOV 11, 2020
A New CDK Inhibitor Could Help with Unresponsive Liver Cancer
Amongst the most common targets of anti-cancer drugs are small regulatory molecules called cyclin-dependent kinases (CDK ...
NOV 08, 2020
Drug Discovery & Development
Psychedelic Mushrooms Effectively Treat Major Depression
NOV 08, 2020
Psychedelic Mushrooms Effectively Treat Major Depression
Over 17 million people in the US and 300 million people worldwide are estimated to have experienced major depression. No ...
NOV 17, 2020
Immunology
6 Injections a Year Prevent HIV Infections
NOV 17, 2020
6 Injections a Year Prevent HIV Infections
Last year, around 1.7 million people became infected with HIV, with around half of these being women. Encouraging result ...
NOV 20, 2020
Drug Discovery & Development
Hyperbaric Oxygen Treatments Reverse Aging
NOV 20, 2020
Hyperbaric Oxygen Treatments Reverse Aging
Researchers from Israel have found that hyperbaric oxygen treatments (HBOT) in healthy aging adults can prevent blood ce ...
DEC 20, 2020
Drug Discovery & Development
Antifungal Drug May Treat Cystic Fibrosis
DEC 20, 2020
Antifungal Drug May Treat Cystic Fibrosis
A fungal-targeting drug was shown to improve symptoms of cystic fibrosis particularly key biomarkers in lung tissue cult ...
DEC 28, 2020
Cell & Molecular Biology
How an Herbal Compound May Fight Pancreatic Cancer
DEC 28, 2020
How an Herbal Compound May Fight Pancreatic Cancer
For centuries, Chinese practitioners have used herbs to treat all kinds of ailments. New research has shown that one of ...
Loading Comments...